Loading...
Probiotic use
Nisin ALactococcus lactis subspLantibiotic type A
Gastrointestinal tract infectionsOral cavityin-vitroAkerey et al.
2009
Skin infectionsHuman mastitisin-vivo (human model)Fernndez et al.
2008
Hospital-acquired infectionsMulti drug resistant strainin vitroPiper et al.
2009
Urogenital tract infectionsspermicidal activity
  • in-vitro
  • in-vivo (rabbit model)
Reddy et al.
2004
Nisin FLactococcus lactis subspLantibiotic type A
Systemic infectionSystemic infectionin-vivo (murine model)Brand et al.
2010
Respiratory tract infectionsPneumonia
  • in-vitro
  • in-vivo (rat model)
De Kwaadsteniet et al.
2009
Respiratory tract infectionsPneumonia
  • in-vitro
  • in-vivo (rat model)
de Kwaadsteniet et al.
2008
Skin infectionsCutaneous infectionin-vivo (murine model)de Kwaadsteniet et al.
2010
Hospital-acquired infectionsMulti drug resistant strainin-vitroPiper et al.
2011
Hospital-acquired infectionsMulti drug resistant strainin-vivo (murine model)van Staden et al.
2012
in-vivo (murine model)van Staden et al.
2011
Nisin ZLactococcus lactis subspLantibiotic type A
Gastrointestinal tract infectionsOral cavityin-vitroAkerey et al.
2009
Skin infectionsbovine mastitisin-vivo (bovine model)Cao et al.
2007
Skin infectionsbovine mastitisin-vivo (bovine model)Wu et al.
2007
Ruminococcin CRuminococcus gnavus E1Lantibiotic type A
Gastrointestinal tract infectionsStomach and intestine infectionsin-vivo (rat model)Crost et al.
2011
MicrobisporicinMicrobispora ATCC PTA-5024Lantibiotic
Hospital-acquired infectionsMulti drug resistant strainin-vitroCastiglione et al.
2008
Hospital-acquired infectionsMulti drug resistant strainin-vitroJabes et al.
2011
Gastrointestinal tract infectionsStomach and intestine infectionsin-vitroLazzarini et al.
2008